SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.
Clinical trial NCT00412334 · COMPLETED
Trial details
- NCT number
- NCT00412334
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2010-09-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.